Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

aliskiren / Hydrochlorothiazide

Known as: ALISKIREN/HYDROCHLOROTHIAZIDE, aliskiren and hydrochlorothiazide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Hypertension is a major risk factor in the development of cardiovascular disease, with myocardial infarction, stroke and renal… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
2014
2014
BACKGROUND Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when… Expand
Review
2013
Review
2013
Objectives Aliskiren, a direct renin inhibitor, is effective for reducing blood pressure (BP) in patients with hypertension when… Expand
2011
2011
Background: Single-pill combinations of aliskiren/hydrochlorothiazide have recently been approved by the European Medicines… Expand
  • table 1
  • table 2
  • table 3
2011
2011
J Clin Hypertens (Greenwich). 2011;13:889–897. ©2011 Wiley Periodicals, Inc. 
2009
2009
OBJECTIVE Thiazide diuretics such as hydrochlorothiazide (HCT) are a widely used first-line treatment for hypertension, but most… Expand
2009
2009
ABSTRACT Objective: Thiazide diuretics such as hydrochlorothiazide (HCT) are a widely used first-line treatment for hypertension… Expand
Review
2008
Review
2008
  • K. Sureshkumar
  • Vascular health and risk management
  • 2008
  • Corpus ID: 16679702
Hypertension is a major risk factor for the development of cardiovascular and renal disease. The incidence of hypertension is… Expand
  • figure 1
  • table 1
2008
2008
  • The Medical letter on drugs and therapeutics
  • 2008
  • Corpus ID: 20025019